FDA: Industry’s Failure To Follow Guidance Increases 510(k) Review Times
This article was originally published in The Gray Sheet
Executive Summary
The top reason FDA sends two or more requests for information during 510(k) reviews is because firms failed to follow guidance or recognized standards, said Christy Foreman, acting director of FDA’s Office of Device Evaluation.